Naef, M
Müller, U
Linssen, A
Clark, L
Robbins, T W
Eisenegger, C
Article History
Received: 22 June 2016
Revised: 15 December 2016
Accepted: 24 January 2017
First Online: 25 April 2017
Competing interests
: UM discloses consultancy for Janssen-Cilag, Lilly, Heptares and Shire, and educational funding from AstraZeneca, Bristol-Myers Squibb, Janssen-Cilag, Lilly, Lundbeck and Pharmacia-Upjohn. AL is an employee of Medpace Medical Device B.V. LC is the Director of the Centre for Gambling Research at UBC, which is supported by the Province of BC government and the British Columbia Lottery Corporation, and has consulted for Cambridge Cognition Ltd. TWR discloses consultancy with Lilly, Lundbeck, Teva, Shire Pharmaceuticals, ChemPartners and Cambridge Cognition Ltd and research grants with Lilly, Lundbeck and GlaxoSmithKline. The remaining authors declare no conflict of interest.